Search Results - "Hepatology, Medicine and Policy"

Refine Results
  1. 1

    Correlates of hepatitis B awareness and disease-specific knowledge among pregnant women in Northern and Central Uganda: a cross-sectional study by Nankya-Mutyoba, Joan, Aizire, Jim, Makumbi, Fredrick, Atuyambe, Lynn, Ocama, Ponsiano, Kirk, Gregory D

    Published in Hepatology, Medicine and Policy (19-12-2018)
    “…Countries in sub-Saharan Africa with a high hepatitis B burden also have limited resources to identify underlying drivers of disease among key at-risk…”
    Get full text
    Journal Article
  2. 2

    Correction to: Hepatology, Medicine and Policy : Articles with DOIs 10.1186/s41124-016-0014-8, 10.1186/s41124-016-0013-9 and 10.1186/s41124-016-0012-x

    Published in Hepatology, Medicine and Policy (19-11-2018)
    “…[This corrects the article DOI: 10.1186/s41124-016-0012-x.][This corrects the article DOI: 10.1186/s41124-016-0013-9.][This corrects the article DOI:…”
    Get full text
    Journal Article
  3. 3

    Strategies for achieving viral hepatitis C micro-elimination in the Netherlands by Kracht, P A M, Arends, J E, van Erpecum, K J, Urbanus, A, Willemse, J A, Hoepelman, A I M, Croes, E A

    Published in Hepatology, Medicine and Policy (29-09-2018)
    “…The Netherlands is striving to achieve national elimination of the hepatitis C virus (HCV) as one of the first countries worldwide. The favorable HCV…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Seroprevalence of hepatitis B and C in Nepal: a systematic review (1973-2017) by Naveira, Marcelo Contardo Moscoso, Badal, Komal, Dhakal, Jagadish, Mayer, Neichu Angami, Pokharel, Bina, Del Prado, Ruben Frank

    Published in Hepatology, Medicine and Policy (06-09-2018)
    “…Hepatitis B and C represent an important co-infection for people living with HIV worldwide. Nepal wants to be part of the international mobilization for viral…”
    Get full text
    Journal Article
  6. 6

    Drug consumption rooms (DCRs) as a setting to address hepatitis C - findings from an international online survey by Belackova, Vendula, Salmon, Allison M, Schatz, Eberhard, Jauncey, Marianne

    Published in Hepatology, Medicine and Policy (22-08-2018)
    “…Prevalence of Hepatitis C Virus (HCV) among people who inject drugs (PWID) is high. Risky injecting behaviours have been found to decrease in drug consumption…”
    Get full text
    Journal Article
  7. 7

    Achieving a hepatitis C cure: a qualitative exploration of the experiences and meanings of achieving a hepatitis C cure using the direct acting antivirals in Australia by Richmond, Jacqueline A, Ellard, Jeanne, Wallace, Jack, Thorpe, Rachel, Higgs, Peter, Hellard, Margaret, Thompson, Alexander

    Published in Hepatology, Medicine and Policy (04-08-2018)
    “…Universal access to the hepatitis C direct acting antiviral (DAAs) regimens presents a unique opportunity to eliminate hepatitis C in Australia. Large numbers…”
    Get full text
    Journal Article
  8. 8

    Racial/ethnic- and county-specific prevalence of chronic hepatitis B and its burden in California by Toy, Mehlika, Wei, Bin, Virdi, Tejpal S, Le, An, Trinh, Huy, Li, Jiayi, Zhang, Jian, Hsing, Ann W, So, Samuel K, Nguyen, Mindie H

    Published in Hepatology, Medicine and Policy (05-06-2018)
    “…In the United States, the highest burden of chronic hepatitis B (CHB) and CHB-related liver cancer is in the state of California, primarily in the San…”
    Get full text
    Journal Article
  9. 9

    Re-evaluation of chronic hepatitis B and hepatitis C patients lost to follow-up: results of the Northern Holland hepatitis retrieval project by Beekmans, N, Klemt-Kropp, M

    Published in Hepatology, Medicine and Policy (31-01-2018)
    “…Many persons infected with Hepatitis B virus (HBV) and Hepatitis C virus (HCV) in the past are now lost to follow-up. The aim of the Northern Holland Hepatitis…”
    Get full text
    Journal Article
  10. 10

    Design of the Prospective Real-world Outcomes Study of hepatic encephalopathy Patients' Experience on Rifaximin-α (PROSPER): an observational study among 550 patients by Krag, Aleksander, Schuchmann, Marcus, Sodatonou, Hanna, Pilot, Jeff, Whitehouse, James, Strasser, Simone I, Hudson, Mark

    Published in Hepatology, Medicine and Policy (08-01-2018)
    “…Hepatic encephalopathy (HE) is one of the most important severe complications of liver cirrhosis. Thought to be caused by elevated blood levels of gut-derived…”
    Get full text
    Journal Article
  11. 11

    Uptake of hepatitis B-HIV co-infection screening and management in a resource limited setting by Rachel, Musomba, Barbara, Castelnuovo, Murphy, Claire, Komujuni, Charlene, Nyakato, Patience, Ocama, Ponsiano, Lamorde, Mohammed, Easterbrook, Philippa, Ratanshi, Rosalind Parkes

    Published in Hepatology, Medicine and Policy (06-01-2018)
    “…WHO hepatitis B guidelines recommend testing all new HIV patients, treating them accordingly or providing immunization. At the Infectious Diseases Institute…”
    Get full text
    Journal Article
  12. 12

    Post-infection viral superinfection technology could treat HBV and HCV patients with unmet needs by Bakacs, Tibor, Safadi, Rifaat, Kovesdi, Imre

    Published in Hepatology, Medicine and Policy (05-01-2018)
    “…Viral hepatitis deaths from acute infection, cirrhosis, and liver cancer have risen from the tenth to the seventh leading cause of death worldwide between 1990…”
    Get full text
    Journal Article
  13. 13

    "B in IT" - a community-based model for the management of hepatitis B patients in primary care clinics using a novel web-based clinical tool by O'Leary, Debra A, Cropp, Eleanor, Isaac, David, Desmond, Paul V, Bell, Sally, Nguyen, Tin, Wong, Darren, Howell, Jessica, Richmond, Jacqui, O'Neill, Jenny, Thompson, Alexander J

    Published in Hepatology, Medicine and Policy (04-01-2018)
    “…The current model of care for the treatment of chronic hepatitis B (CHB) in Australia is through specialist Hepatology or Infectious Diseases clinics, and…”
    Get full text
    Journal Article
  14. 14

    Erratum: Publisher Correction to Hepatology, Medicine and Policy : Articles with DOIs 10.1186/s41124-017-0024-1, 10.1186/s41124-017-0025-0, 10.1186/s41124-017-0026-z and 10.1186/s41124-017-0027-y

    Published in Hepatology, Medicine and Policy (2018)
    “…[This corrects the article DOI: 10.1186/s41124-017-0027-y.][This corrects the article DOI: 10.1186/s41124-017-0026-z.][This corrects the article DOI:…”
    Get full text
    Journal Article
  15. 15

    Hepatitis C virus prevention and care for drug injectors: the French approach by Delile, Jean-Michel, de Ledinghen, Victor, Jauffret-Roustide, Marie, Roux, Perrine, Reiller, Brigitte, Foucher, Juliette, Dhumeaux, Daniel

    Published in Hepatology, Medicine and Policy (2018)
    “…After France removed hepatitis C treatment reimbursement restrictions on 25 May 2016, an expert report presented recommendations, which focused on vulnerable…”
    Get full text
    Journal Article
  16. 16

    Urgent action to fight hepatitis C in people who inject drugs in Europe by Dillon, John F, Lazarus, Jeffrey V, Razavi, Homie A

    Published in Hepatology, Medicine and Policy (2016)
    “…Hepatitis C virus (HCV) infection is a leading cause of liver cirrhosis and liver cancer, is curable in most people. Injecting drug use currently accounts for…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Hepatitis C in Eastern Europe and Central Asia: a survey of epidemiology, treatment access and civil society activity in eleven countries by Maistat, Ludmila, Kravchenko, Natalija, Reddy, Amulya

    Published in Hepatology, Medicine and Policy (13-06-2017)
    “…The 16 countries of the Eastern Europe and Central Asia (EECA) region are home to 6.6 million people in need of treatment for chronic hepatitis C virus (HCV)…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Incidence of hepatitis C among people who inject drugs in Ireland by Carew, Anne Marie, Murphy, Niamh, Long, Jean, Hunter, Kate, Lyons, Suzi, Walsh, Cathal, Thornton, Lelia

    Published in Hepatology, Medicine and Policy (26-01-2017)
    “…Comprehensive information on the incidence and duration of hepatitis C virus (HCV) infection for people who inject drugs (PWID) in Ireland is not available. We…”
    Get full text
    Journal Article